JULY WEBINAR: IMPACT OF PROTEOMICS ON COVID

Learn About Our Upcoming Webinar!

HUPO Connect 2020 kicks off with a series of 60-minute webinars taking place in July, August and September in which the very best of proteomics research will be presented as a prelude to the main Congress sessions. All webinars are free for HUPO Members, and $10.00 USD for Non HUPO Members. Non Members can sign up for HUPO's Mailing List during the registration process and receive complimentary registration!

Mark your calendars for Tuesday, July 21, 2020 for our first Pre-Congress Webinar!

Attendees will be able to submit questions and/or comments via a text chat feature and a live audio Q&A facilitated by the Session Chair will take place immediately following the presentations.

Impacts of Proteomics on COVID

Date: Tuesday, July 21, 2020
Time: 07:00 PDT (UTC-7), 10:00 EDT (UTC-4), 14:00 UTC, 22:00 CST (UTC+8), 00:00 AEST (UTC+10). Note that UTC stands for Coordinated Universal Time.

Register for the Webinar
This webinar will be moderated by Perdita Barran and will branch into two presentations with two featured speakers.

Presentations

A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing - Nevan Krogan

Proteomic Characterization of COVID-19 Patient Sera - Tiannan Guo

Learn About Our Speakers & Chair

In order to learn more about each individual speaker, please click on the photos below.

United Kingdom

Perdita Barran

Professor Barran holds a Chair of Mass Spectrometry in the School of Chemistry and is Director of the Michael Barber Centre for Collaborative Mass Spectrometry at the Manchester Institute of Biotechnology, The University of Manchester, UK. From 2002-2013 she was at the University of Edinburgh as an EPSRC Advanced Research Fellow, Senior Lecturer and then Reader in Biophysical Chemistry. She graduated from Manchester University with a degree in Chemistry with Industrial Experience (1994), and from Sussex University with a PhD in Chemical Physics (1998) under the supervision of Professors Tony Stace and Sir Harry Kroto. She worked as a post-doctoral researcher for Tony Stace, before moving to the University of California Santa Barbara to work with Mike Bowers. Her research interests include: Biological mass spectrometry; Instrument and technique development; Protein structure and interactions; Dynamic and Disordered Systems; Parkinson’s disease Diagnostics; HDX-MS; Proteomics; and Molecular modeling. She is a Fellow of the Royal Society of Chemistry and was awarded the Theophilius Redwood Award from the RSC in 2019, Researcher of the Year 2020 from the University of Manchester and the ACS Measurement Science Lectureship 2021. Perdita has authored over 140 publications in peer reviewed journals which have been cited over 4000 times, by people other than her.

China

Tiannan Guo

Tiannan Guo received training of clinical medicine in Tongji Medical College, Huazhong University of Science and Technology (1999-2006), and biology in Wuhan University (2001-2005), before he moved to Singapore for PhD training in cancer proteomics in the laboratories of Dr. Newman Sze in Nanyang Technological University and Dr.Oi Lian Kon in National Cancer Centre Singapore (2008-2012). In 2012, Tiannan started his postdoctoral training in the laboratory of Dr. Ruedi Aebersold in ETH Zurich. In March 2017, Tiannan relocated to ProCan, Children’s Medical Research Institute, The University of Sydney as the Scientific Director. Since August 2017, he became a Tenure Track Assistant Professor in Westlake University, Hangzhou, China. The Guo lab (www.guomics.com) focuses on advancing proteomics technologies for clinical cohort studies.

United States

Nevan Krogan

Nevan Krogan, PhD, is a molecular biologist, UC San Francisco professor, and director of the intensely interdisciplinary Quantitative Biosciences Institute (QBI) under the UCSF School of Pharmacy. He is also a senior investigator at the Gladstone Institutes.
He led the work to create the SARS-CoV-2 interactome and assembled the QBI Coronavirus Research Group (QCRG), which includes hundreds of scientists from around the world. His research focuses on developing and using unbiased, quantitative systems approaches to study a wide variety of diseases with the ultimate goal of developing new therapeutics.
Nevan serves as Director of The HARC Center, an NIH-funded collaborative group that focuses on the structural characterization of HIV-human protein complexes. Dr. Krogan is also the co-Director of three Cell Mapping initiatives, the Cancer Cell Mapping Initiative (CCMI), the Host Pathogen Map Initiative (HPMI) and the Psychiatric Cell Map Initiative (PCMI). These initiatives map the gene and protein networks in healthy and diseased cells with these maps being used to better understand disease and provide novel therapies to fight them.
He has authored over 250 papers in the fields of genetics and molecular biology and has given over 250 lectures and seminars around the world. He is a Searle Scholar, a Keck Distinguished Scholar and was recently awarded the Roddenberry Prize for Biomedical Research.